Early in an immune response, B cells latch on to antigens embedded in the surface membranes of follicular dendritic cells and macrophages. Engagement with antigen spurs a flurry of activity at the point of contact on the B cell surface-a phenomenon that Facundo Batista is documenting in molecular detail. During his post-doctoral research, Batista discovered that B cell receptors (BCRs) must exceed an affinity threshold to trigger B cell activation (1) . He also found that B cells form an organized molecular structure, known as an immunological synapse, when they encounter membrane-tethered antigen. BCRs accumulate antigens at the synapse, then extract and internalize them for subsequent presentation to T cells (2) .
After Batista set up his own laboratory at the London Research Institute, he began to follow these events in real time. His studies revealed that antigen-bound B cells reorganize their actin cytoskeleton to first spread across the surface of the antigen presenting cell and then to contract their membranes, concentrating the antigen at the synapse within a ring of adhesion molecules (3). High affinity antigens induce more spreading than low affinity antigens, leading to increased antigen capture.
Using a mathematical model based on this data, Batista's group hypothesized that deactivating the spreading mechanism would prevent cells from distinguishing between high and low affinity antigens-a prediction confirmed by their later experiments with spreading-defective B cells. The group has since identified the signaling molecules and pathways that enhance B cell adhesion at the synapse and contribute to activation (4-6). They have now begun to use multi-photon microscopy techniques to image B cell behavior in real time in living tissue.
A NOBEL INSPIRATION
How did your journey into science begin? Growing up in Argentina, I was really into things that involved nature and biology, and wanted to make documentaries about the Antarctic and things like that. But my interests changed when I started undergraduate studies at the University of Buenos Aires. I heard two professors, Daniel Goldstein and Alberto Kornblihtt, lecture on their research in molecular biology and I was hooked.
How did you end up earning a PhD in immunology from a program in Italy?
Ever since the military started to persecute university professors and other free thinkers in the 1960s, there was always a wave of scientists leaving the country. I came of age much later of course, but I also wanted to go abroad to study, as many of my friends were doing. So I took the necessary exams and was accepted at the International Center for Genetic Engineering and Biotechnology in Trieste, Italy.
At the time, I became interested in immunology because of César Milsteinan Argentinean scientist who won the Nobel Prize for his research on monoclonal antibodies. Inspired by his work, I joined Oscar Burrone's laboratory to work on the assembly of immunoglobulin E isoforms on the B cell surface.
ATTRACTED BY AFFINITY
Why did you move to England for postdoctoral work? After I fi nished my PhD, I wanted to work on B cell activation, a fi eld in which Michael Neuberger was doing brilliant work. I got a European Molecular Biology Laboratory (EMBL) fellowship to work in his laboratory in Cambridge for fi ve years. Michael really shaped my attitude toward research by showing me how to think about science and ask questions that were wider in scope.
What problem did you work on in Michael's laboratory? I was trying to understand how the affi nity of interaction between the BCR and antigen impacted B cell activation. We fi rst studied this issue using soluble antigens. We found that there was a minimum affi nity threshold to activate the BCR and that the cells are very good at discriminating between affi nities that are in the lower range. But the capacity of B cells to discriminate between higher range affi nities is not so good, which suggests there is a "ceiling" during affi nity maturation. 
What was your next step?
The studies I did with Michael were very interesting, but they were limited by their static nature. So when I set up 
What's the advantage of this technique?
We can put specifi c ligands at any concentration onto lipid bi-layers on glass cover-slips. This gives us a unique focal plane for microscopy and allows us to be very quantitative about the information we get when cells bind to these ligands. The system allows us to study isolated receptors or the cooperation between two or more receptors or their interaction with other surface molecules. We used this system to show that B cells are better at recognizing low affi nity antigens thanks to the activity of adhesion molecules such as LFA-1 on the B cell surface, which aid cell attachment and allow sampling of a greater area of the antigenpresenting surface.
How did you discover membrane spreading and contraction?
We realized that after initial antigen contact, it took ∼10 min for the synapse to form. So we started to look more closely at what was happening at the surface during these early moments. My student Sebastian Fleire wanted to look at the cells interacting with antigens using electron microscopy. I thought the idea was rubbish because I didn't think he would see anything interesting that way. But he came back with these amazing pictures; I never thought the spreading process would be so dramatic. And what was more interesting was that this process was driven by the cell's cytoskeleton. The B cell cytoskeleton has very much been ignored over the years, but not anymore.
MICROCLUSTERS AND

MODELING
How does the cytoskeleton drive signaling?
The powerful combination of artifi cial lipid bilayers and total internal refl ection microscopy showed us that cells polymerize actin and form surface microclusters of BCR and antigen as they spread. BCR engagement triggers the activation of a small GTPase called Rac2, which in turn activates the adhesion molecule LFA-1-so this is a form of inside-out signaling that increases B cell adhesion. Antigen binding also initiates the recruitment of other positive regulators such as CD19, which is critical for B cell activation in vivo. The microclusters thus form a platform for the assembly of all these molecules into what we've named "microsignalosomes".
Some molecules, such as CD19, are dynamically recruited to the BCR. Other bulkier molecules such as CD45 are excluded. This size-dependent exclusion fits the "kinetic-segregation" mechanism postulated by Anton van der Merwe and colleagues. Are you also looking at these phenomena in vivo? Yes. Yolanda Carrasco, one of my very talented post-docs, recently used twophoton microscopy to track antigen in vivo, and identifi ed the precise area in the lymph nodes where B cells acquire particulate antigen. We're now trying to improve the resolution at which we can study this interaction. I've realized that it's one thing to buy a fancy microscope, but the key is to develop techniques to use it in the most eff ective way and push the limits of what we can use it for. I've started to do this by bringing people who are experts in microscopy and physics into my group.
How does mathematical modeling come into play in your work?
Our collaboration with Dennis Bray enabled us to appreciate the importance of mathematical modeling. The beauty of modeling is that we can answer questions about things we've yet to test biologically. We can include more parameters and get faster answers. This method pointed us toward the fact that a cell that will not be able to spread and contract will not be able to sense diff erences in ligand affi nity.
Modeling is often criticized because people question the in vivo relevance of the data we get. For me, both approaches (theoretical and experimental) are essential and valid because we only learn more when a process that's been studied in vivo is revisited in a quantitative way, and vice versa.
